A biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer.
Product Pipeline
Coronado Biosciences is sponsoring and will be walking in New York City’s Take Steps for Crohn's & Colitis.
Please click here to find out more about the Crohn’s & Colitis Foundation and the walk.
Investor Area
Recent News
May 15, 2012:
Coronado Biosciences Reports First Quarter 2012 Financial Results.
May 10, 2012:
Coronado Biosciences to Report First Quarter 2012 Financial Results.
May 1, 2012:
Coronado Biosciences Announces Phase 1 TSO Data to be Presented at the 8th International Congress of Autoimmunity.
